Shilpa Gefitinib Tablets IP 250 mg

Name: Shilpa Gefitinib Tablets IP 250 mg
Brand: Maheshwari Medical Agency
Price: 400 INR
Availability: InStock

Price 400 INR/ Strip

Get a Price/Quote

MOQ : 10 Strips

Shilpa Gefitinib Tablets IP 250 mg Specification

Indication
Non-Small Cell Lung Cancer (NSCLC)

Origin
India

Salt Composition
Gefitinib IP 250 mg

Dosage Form
Tablets

Feature
Once daily oral targeted therapy

Ingredients
Gefitinib, Excipients

Application
Anticancer therapy

Physical Color/Texture
Light brown, round, film-coated tablets

Fermentation Smell
Odorless

Storage Instructions
Keep dry & cool place

Shelf Life
24 months

Expiry Details
See packaging for expiry date

ATC Code
L01XE02

Prescription Status
Prescription only medicine

Packaging Size
30 tablets per bottle

Administration Route
Oral

Warning
To be sold by retail on the prescription of an Oncologist only

Contraindications
Hypersensitivity to Gefitinib

Market Authorization Holder
Shilpa Medicare Limited

Storage Condition
Keep container tightly closed

International Nonproprietary Name (INN)
Gefitinib

Brand Name
Geficin

Strength
250 mg per tablet

Batch/Lot Number
Available on packaging

Common Side Effects
Diarrhea, skin rash, dry skin, nausea

Shilpa Gefitinib Tablets IP 250 mg Trade Information

Minimum Order Quantity
10 Strips

Supply Ability
1000 Strips Per Month

Delivery Time
7 Days

About Shilpa Gefitinib Tablets IP 250 mg

Discover the superlative efficacy of Shilpa Gefitinib Tablets IP 250 mg-an eminent prescription-only medicine, celebrated as a paragon of targeted anticancer therapy. Crafted by Shilpa Medicare Limited and marketed under the brand name Geficin, each tablet delivers a potent 250 mg dosage of Gefitinib. With convenient once-daily oral administration, these light brown, film-coated tablets are designed for the precise management of Non-Small Cell Lung Cancer (NSCLC). For unmatched savings and assurance of quality, shop now with confidence. Markdown prices available. Always consult your oncologist before use.

Ideal Use and Applications for Shilpa Gefitinib Tablets IP 250 mg

Shilpa Gefitinib Tablets IP 250 mg is suitable for adult patients diagnosed with Non-Small Cell Lung Cancer (NSCLC), as prescribed by an oncologist. Its use type is strictly prescription-based, emphasizing safe and appropriate administration. The medicine serves as an oral, targeted anticancer therapy, making it convenient and effective for daily use. Application revolves around inhibiting cancer cell growth, ensuring care and efficacy when used under medical supervision.

Packing & Dispatch: Reaching Export and Domestic Markets Swiftly

Our packing & dispatch process guarantees product integrity for both domestic and international clients. Shilpa Gefitinib Tablets IP 250 mg is available for quick dispatch, serving eminent export markets in Asia, Africa, and Europe, as well as the main domestic market across India. Adhering to a transparent sample policy, our goal is efficient delivery, robust export market connectivity, and customer satisfaction for pharmaceutical distributors, suppliers, and traders.

FAQ's of Shilpa Gefitinib Tablets IP 250 mg:

Q: How should Shilpa Gefitinib Tablets IP 250 mg be administered?

A: Shilpa Gefitinib Tablets are taken orally, once daily, with or without food. Always follow your oncologist's prescription regarding dosage and timing.

Q: What are the key benefits of using Geficin (Gefitinib) for NSCLC?

A: Geficin offers targeted therapy for Non-Small Cell Lung Cancer, focusing directly on cancer cells to inhibit growth, which often leads to improved patient outcomes and convenience via its once-daily dosing.

Q: When should I consult a healthcare professional before starting this medication?

A: Consult your oncologist before beginning Shilpa Gefitinib Tablets, as it is a prescription-only drug and not suitable for everyone, especially those with hypersensitivity to Gefitinib.